AMLX vs GILD: Which Stock is Better?

Side-by-side comparison of Amylyx Pharmaceuticals Inc and Gilead Sciences Inc in 2026

Comparison Updated:

AMLX

Amylyx Pharmaceuticals Inc

$14.29

GILD

Gilead Sciences Inc

$144.40

Key Metrics Comparison

MetricAMLXGILDWinner
Market Cap$1.59B$180.27BGILD
P/E RatioN/A21.42GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth-1.0%0.0%GILD
Gross Margin13594.6%78.8%AMLX

Analyze AMLX

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMLX or GILD a better investment?

Comparing AMLX and GILD: Amylyx Pharmaceuticals Inc has a market cap of $1.59B while Gilead Sciences Inc has $180.27B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMLX and GILD?

AMLX (Amylyx Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMLX or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AMLX or GILD?

GILD has higher revenue growth at 0.0% vs -1.0% for AMLX.

Which company is more profitable: AMLX or GILD?

Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 13594.6% compared to 78.8% for GILD.

Which is the larger company: AMLX or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $180.27B compared to $1.59B for AMLX.

Should I buy AMLX or GILD in 2026?

Both AMLX and GILD have investment merit. AMLX trades at $14.29 while GILD trades at $144.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMLX and GILD stock?

Key differences: Market Cap ($1.59B vs $180.27B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (13594.6% vs 78.8%).

Popular Stock Comparisons